Firdaus | Sofia | Nurainiza | Hafizah

Slides:



Advertisements
Similar presentations
HOW DO DRUGS GET INTO THE BODY?. WHY BE CONCERNED ABOUT HOW DRUGS GET INTO BODY? Bioavailability - % of dose that gets into body Bioequivalence - similarity.
Advertisements

III. Drug Metabolism  The aim of drug metabolism is to convert lipid soluble (non polar) drugs to polar metabolites easily excreted in urine.  The liver.
MODIFIED RELEASE DOSAGE FORM
Which Diltiazem? June There are 4 different formulations of diltiazem and 9 different products Plain SR CD LA.
Pharmaceutics 2 & 3 صيدلانيات 2&3 Unit / second semester Transdermal drug delivery system.
Pharmacokinetics & Pharmacodynamics of Controlled Release Systems Presented By: Govardhan.P Dept. of pharmaceutics, University College of Pharmaceutical.
 Modified drug release dosage forms:  These dosage forms are designed to release drugs in a controlled manner, at a predetermined rate, duration and.
Insulin therapy.
Routes of Drug Administration
How and Why Drugs Work Chapter 5
The Pharmaceutical Composition Methodology described in this presentation has been developed to improve controlled drug delivery through site specific.
10/1/20151 BIOPHARMACEUTICS, NEW DRUG DELIVERY SYSTEMS & DEVICES A. S. Adebayo, Ph.D.
Mosby items and derived items © 2007 by Mosby, Inc., an affiliate of Elsevier Inc. Chapter 2 Drug Action and Handling.
1.  Drug delivery is the method or process of administering pharmaceutical compound to achieve a therapeutic effect in humans or animals.  Most common.
© 2004 by Thomson Delmar Learning, a part of the Thomson Corporation. Fundamentals of Pharmacology for Veterinary Technicians Chapter 3 Therapeutic Range.
Bioavailability Dr Mohammad Issa.
Calculating Oral Dosage
DELIVERY OF PROTEINS USING BIODEGRADABLE POLYMERS Mahesh V. Chaubal Guilford Pharmaceuticals Inc. Baltimore, MD 21224
1 Controlled drug release Dr Mohammad Issa. 2 Frequency of dosing and therapeutic index  Therapeutic index (TI) is described as the ratio of the maximum.
CHEE 4401 Definitions drug - any substance that affects the structure or functioning of an organism pharmaceutics - the area of study concerned with the.
The Pharmaceutical Composition Methodology described in this presentation has been developed to improve controlled drug delivery through site specific.
Chapter 3 Principles and Methods of Drug Administration Copyright © 2011 Delmar, Cengage Learning.
Bioavailability Dr. Basavaraj K. Nanjwade M. Pharm., Ph. D Department of Pharmaceutics Faculty of Pharmacy Omer Al-Mukhtar University Tobruk, Libya.
Pharmacokinetics of Drug Absorption Dr. Basavaraj K. Nanjwade M. Pharm., Ph. D Department of Pharmaceutics Faculty of Pharmacy Omer Al-Mukhtar University.
Pharmacology Basics Presentation Name Course Name
Modified release products. Considerations in the evaluation of modified release products Requirements for preparing extended release products. The bioavailability.
 1-What is the best drug to be used?  2-How it is going to be given?
Design of Sustained Release Dosage Forms
Theophylline in broncial asthma. By:Heba Othman Essam El-Din Pharm –D4(2009).
PHT 415 BASIC PHARMACOKINETICS
OVER THE COUNTER MEDS INTRODUCTION No prescriptions are necessary and no questions need to be answered to attain these drugs OTC med use saves.
Sayed Ali Mus POST GRADUATES-BATCH 6 FACULTY OF MEDICAL LABORATORY SCIENCES PARASITOLOGY DEPARTMENT ALNEELIN UNIVERSITY March 2015 Symposium on: Advances.
Downloaded from نور آغا ”محمدی“ سهراب عبدالله ”عطائی“ محمد اقبال محبوب الله ”دگروال“ سمیع الله ”گرده “ زبیر ”بنیادی“ عبدالمقسط.
PHARMACEUTICAL GUIDELINES: BASIC PRINCIPLES AND STATUTES.
routes of drug administration By Hawra alsofi
Pharmacology Basics Presentation Name Course Name
Life Span Consideration
Omitted, Delayed or Early Medication Doses
Solid dosage forms Tablets
Pharmacology Basics Presentation Name Course Name
Chapter 2 Principles of Drug Action and Drug Interactions
NADIA AMIR AMIRAH FATIN SIR NOOR MUHAMMAD SYAHRIN BIN YAHYA
ABSTRACT Influence of Different Content of Lactose on the Release of Diclofenac Sodium Formulated in Controlled Release Matrix Tablets Containing.
Biopharmaceutics of modified release drug products
Biopharmaceutics factors affecting Modified release products
Chapter 1 Introduction to Biopharmaceutics & Pharmacokinetics
Controlled drug release
Novel Drug Delivery System
Group members: Firdaus | Sofia | Nurainiza | Hafizah
اسید های چرب ضروری غیر اشباع
Pharmacology.
Clinical Pharmacokinetics
Pharmacology: Outcome: I can learn the proper terminology and abbreviations to be able to accurately read prescriptions. Drill: How many lobes does the.
Pharmacokinetics and Factors of Individual Variation
HHV ⁵014 NUTRACEUTICAL FORMULATION TECHNOLOGY
Pharmacokinetics: Drug Absorption
Drug Delivery Systems Pharmaceutical technology Petra University.
Pharmacology Basics Presentation Name Course Name
Dose measurement Lecturer: dr. Asmaa abdelaziz Mohamed
Selected Bioavailability and Pharmacokinetic Calculations
1 Concentration-time curve
Basic Biopharmaceutics
Therapeutic Drug Monitoring chapter 1 part 1
How and Why Drugs Work Chapter 5
Biopharmaceutics 4th year
Principles and Methods of Drug Administration
FIRDAUS HAFIZAH SOFIA AINIZA
Introduction to Clinical Pharmacology Chapter 4 The Nursing Process
Chapter 11 Oral Dosages Copyright © 2020 by Mosby, an imprint of Elsevier Inc. All rights reserved.
POLYPHARMACY.
Presentation transcript:

Firdaus | Sofia | Nurainiza | Hafizah HHV 5014 NUTRACEUTICAL FORMULATION TECHNOLOGY Unit 4: Introduction To Solid Dosage Form Nutraceutical (4.1: Delivery System) Group members: Firdaus | Sofia | Nurainiza | Hafizah

INTRODUCTION Some drugs are inherently long lasting and require only once-a-day oral dosing to sustain adequate drug blood levels and the desired therapeutic effect. Multiple daily dosing is inconvenient for the patient and can result in missed doses, madeup doses, and noncompliance with the regimen. Extended-release tablets and capsules are commonly taken only once or twice daily, compared with counterpart conventional forms that may have to be taken three or four times daily to achieve the same therapeutic effect.

Advantages of extended-release dosage forms over conventional forms Less fluctuation in drug blood levels Frequency reduction in dosing Enhanced convenience and compliance Reduction in adverse side effects Reduction in overall health care costs

Type of delivery system Modified release Extended release Delayed release Repeat action Targeted release

Modified release Extended release Delayed release Use to describe dosage forms having drug release features based on time, course, and/or location that are designed to accomplish therapeutic or convenience objectives not offered by conventional or immediate-release forms Extended release FDA defines an extended-release dosage form as one that allows a reduction in dosing frequency from that necessitated by a conventional dosage form, such as a solution or an immediate-release dosage form Delayed release is designed to release the drug at a time other than promptly after administration. The delay may be time based or based on the influence of environmental conditions, like gastrointestinal pH.

Repeat action Targeted release Usually contain two single doses of medication, one for immediate release and the second for delayed release. Two-layer tablets, for example, may be prepared with one layer of drug for immediate release with the second layer designed to release drug later as either a second dose or in an extended-release manner. Targeted release Drug release directed toward isolating or concentrating a drug in a body region, tissue, or site for absorption or for drug action.

CONCLUSION Modified release Extended release Delayed release Extended-release dosage forms is more preferred over conventional forms. There are 5 types of delivery system: Modified release Extended release Delayed release Repeat action Targeted release